Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
sponsored a 24-week, randomized, placebo-controlled obesity trial (N=536) testing oral AOD-9604 at doses of 1 mg, 5 mg, 10 mg, and 20 mg daily
We urge you to join usbecome a member of PAS to amplify your voice, support by donating, and taking part in our vital research into areas like SC administration and individualised frequency, and like and follow us on social media to ensure this consistent message reaches every corner of the healthcare system
AOD9604 (anti-obesity drug 9604) is a peptide linked to weight loss
Initial Treatment: For severe cases, doses can be 1000 mcg to 2000 mcg
US$ 20.96
US$ 26.07
US$ 28.82
US$ 29.23
US$ 28.61
US$ 29.32
